Imidazole derivatives as antiparasitic agents and use of molecular modeling to investigate the structure–activity relationship

Importance of monodentate mono-ligand designs in developing N-stabilized Pd catalysts for efficient ambient temperature C C coupling: Donor strengths and steric features

(2019) Abiodun Omokehinde Eseola et al.   Molecular Catalysis

Exploring Amino Acid-Capped Nanoparticles for Selective Anti-Parasitic Action and Improved Host Biocompatibility

(2018) Oluyomi Stephen Adeyemi et al.   Journal of Biomedical Nanotechnology

ESIPT-capable 2,6-di(1H-imidazol-2-yl)phenols with very strong fluorescent sensing signals towards Cr(iii), Zn(ii), and Cd(ii): molecular variation effects on turn-on efficiency

(2018) Abiodun O. Eseola et al.   NEW JOURNAL OF CHEMISTRY

Metal nanoparticles restrict the growth of protozoan parasites

(2018) Oluyomi Stephen Adeyemi et al.   Artificial Cells Nanomedicine and Biotechnology

A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis

(2018) Cristian Rocha-Roa et al.   Frontiers in Cellular and Infection Microbiology

Cellular apoptosis of HFF cells by inorganic nanoparticles not susceptible to modulation by Toxoplasma gondii infection in vitro

(2018) Oluyomi Stephen Adeyemi et al.   TOXICOLOGY IN VITRO

Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential

(2017) Oluyomi Stephen Adeyemi et al.   International Journal of Nanomedicine

Synthesis and antileishmanial activity of 1,3-bis(aryloxy)propan-2-amines

(2017) Stefânia N. Lavorato et al.   MEDICINAL CHEMISTRY RESEARCH

Screening of chemical compound libraries identified new anti-Toxoplasma gondii agents

(2017) Oluyomi Stephen Adeyemi et al.   PARASITOLOGY RESEARCH

Antioxidant properties, phenolic composition, bioactive compounds and nutritive value of medicinal halophytes commonly used as herbal teas

(2017) M. Qasim et al.   SOUTH AFRICAN JOURNAL OF BOTANY

Drugs in development for toxoplasmosis: advances, challenges, and current status

(2017) Holland Alday et al.   Drug Design Development and Therapy

Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis

(2014) Katarzyna Dzitko et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro phenotypic screening of 7-chloro-4-amino(oxy)quinoline derivatives as putative anti- Trypanosoma cruzi agents

(2014) Cristina Fonseca-Berzal et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Toxoplasmosis – A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries

(2014) Jaroslav Flegr et al.   PLoS One

Current Treatment of Toxoplasma Retinochoroiditis: An Evidence-Based Review

(2014) Meredith Harrell et al.   Journal of Ophthalmology

A Focused Small-Molecule Screen Identifies 14 Compounds with Distinct Effects on Toxoplasma gondii

(2012) Edwin T. Kamau et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Electronic/substituents influence on imidazole ring donor–acceptor capacities using 1H-imidazo[4,5-f][1,10]phenanthroline frameworks

(2012) Abiodun O. Eseola et al.   NEW JOURNAL OF CHEMISTRY

Luminescent properties of some imidazole and oxazole based heterocycles: Synthesis, structure and substituent effects

(2010) Abiodun O. Eseola et al.   DYES AND PIGMENTS

Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles

(2010) André P. Liesen et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY